WeLeader Biomedical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,001	991.13	940.7	1,036	841.14
Revenue Growth (YoY)	6.43%	5.36%	-9.17%	23.13%	-
Cost of Revenue	686.53	674.8	642.62	743.97	622.22
Gross Profit	314.67	316.32	298.08	291.75	218.92
Selling, General & Admin	104.38	102.13	100.59	97.64	86.26
Operating Expenses	104.34	102.19	100.12	97.11	86.65
Operating Income	210.33	214.14	197.96	194.64	132.28
Interest Expense	-5.86	-5.8	-5.69	-4.21	-6.16
Interest & Investment Income	1.44	1.29	0.59	0.24	0.08
Other Non Operating Income (Expenses)	4.9	5.2	2.27	1.88	4.85
EBT Excluding Unusual Items	210.82	214.83	195.13	192.54	131.04
Gain (Loss) on Sale of Investments	0.3	0.4	0.1	-0.68	0.01
Gain (Loss) on Sale of Assets	-0.02	-0.02	-1.69	0.69	0.41
Pretax Income	211.1	215.21	193.55	192.55	131.46
Income Tax Expense	44.14	44.99	41.26	38.75	25.69
Net Income	166.96	170.21	152.28	153.8	105.77
Net Income to Common	166.96	170.21	152.28	153.8	105.77
Net Income Growth	9.64%	11.77%	-0.98%	45.40%	-
Shares Outstanding (Basic)	42	42	41	30	28
Shares Outstanding (Diluted)	42	42	41	30	28
Shares Change (YoY)	2.60%	1.55%	35.00%	8.28%	-
EPS (Basic)	3.97	4.09	3.74	5.13	3.79
EPS (Diluted)	3.96	4.08	3.71	5.05	3.76
EPS Growth	6.68%	9.97%	-26.53%	34.31%	-
Free Cash Flow	118.83	108.06	117.13	-379.09	216.43
Free Cash Flow Per Share	2.82	2.59	2.85	-12.46	7.70
Dividend Per Share	3.370	3.370	2.300	0.860	0.450
Dividend Growth	46.52%	46.52%	167.44%	91.11%	-
Gross Margin	31.43%	31.92%	31.69%	28.17%	26.03%
Operating Margin	21.01%	21.61%	21.04%	18.79%	15.73%
Profit Margin	16.68%	17.17%	16.19%	14.85%	12.57%
Free Cash Flow Margin	11.87%	10.90%	12.45%	-36.60%	25.73%
EBITDA	238.91	242.96	227.58	226.65	165.64
EBITDA Margin	23.86%	24.51%	24.19%	21.88%	19.69%
D&A For EBITDA	28.57	28.83	29.62	32.01	33.36
EBIT	210.33	214.14	197.96	194.64	132.28
EBIT Margin	21.01%	21.61%	21.04%	18.79%	15.73%
Effective Tax Rate	20.91%	20.91%	21.32%	20.13%	19.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.